Ferumoxytol-enhanced Magnetic Resonance Imaging
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 185 participants.
Also called NCT02954510
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 185 participants
- Sponsor
- Registry
-
NCT02954510
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT02954510. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-02-01 (actual); primary completion 2023-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ferumoxytol-enhanced Magnetic Resonance Imaging
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- ferumoxytol
- Lead sponsor
- Brigham and Women's Hospital
Record details
- Record id
cardio:ct-nct02954510- Content hash
fcc270840359e13d3afb4467812701113e04a1735ad4b976bf5b70329f5d646e